Recombinant human interleukin-2(Kento)

重组人白细胞介素-2(Kento)

Report date: 2022/01/17 12:14:22

Base Information

Drug NameRecombinant human interleukin-2(Kento)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaDiscontinued
Originator CompaniesKento Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKento Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A